FIELD: medicinal endocrinology, pharmacy. SUBSTANCE: invention relates to application of α-cyclodextrine by the novel designation, namely, for providing oral administration of peptide analogs of releasing-hormone of luteininzing hormone (LH-RH). Invention involves also data about pharmaceutical compositions comprising α-cyclodextrin or its derivatives and mentioned peptide analogs of LH-RH. Proposed agent provides elimination of endocrinological disorders in women. EFFECT: valuable medicinal properties of composition, expanded assortment of non-invasive agents. 34 cl, 7 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANALOGUES OF PEPTIDE LH-RF, THEIR APPLICATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 1998 |
|
RU2212247C2 |
| METASTIN DERIVATIVES AND USE THEREOF | 2007 |
|
RU2454425C2 |
| METASTIN DERIVATIVES AND APPLICATION THEREOF | 2006 |
|
RU2430107C2 |
| NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| PYRIMIDINE COMPOUND OR ITS SALT | 2020 |
|
RU2787992C1 |
| NOVEL ANALOGUES OF GLUCAGON-LIKE PEPTIDE, COMPOSITION AND METHOD OF USE | 2010 |
|
RU2557301C2 |
| 5-ARYL-1H-1,2,4-TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | 2000 |
|
RU2249588C2 |
| ANTAGONISTIC ANALOGUES OF GROWTH HORMONE RELEASING-HORMONE (GH-RH) INHIBITING INSULIN-LIKE GROWTH FACTORS (IGF-I AND -II) | 1999 |
|
RU2235099C2 |
| CALICHEAMICIN DERIVATIVES AND THEIR ANTIBODY-DRUG CONJUGATES | 2018 |
|
RU2732568C1 |
